Magnetic Nanoparticles in Human Health and Medicine. Группа авторов

or in the phase of clini...

      3 Chapter 4Table 4.1 An overview of various biomaterials for tissue engineering applic...

      4 Chapter 8Table 8.1 SPIONs theranostics contributions.

      5 Chapter 9Table 9.1 Characteristics of preclinical imaging techniques with biomedical ...Table 9.2 Physicochemical characteristics of SPECT and PET emitters.Table 9.3 Most commonly used SPECT/PET emitters for Nuclear/MR or multimodal...

      6 Chapter 10Table 10.1 Magnetic nanoparticles with potential use in hyperthermia and rel...Table 10.2 Synthesis methods of magnetic nanoparticles and alloys.

      7 Chapter 11Table 11.1 Summary of important applications of MNP in drug delivery and mag...Table 11.2 Biopharmaceutical classification system (BCS).

      8 Chapter 12Table 12.1 Reduction in RFAMF‐induced heating efficiency with increasing med...Table 12.2 Essential magneto‐structural properties of the phosphate and TMAO...

      9 Chapter 13Table 13.1 Magnetization and magnetic behavior of nanoparticles according to...Table 13.2 Classification of the lipid‐based liposome‐like vesicles and thei...Table 13.3 Classification of nonlipid‐based liposome‐like vesicles and their...Table 13.4 Benefits and limitations in cyclodextrin use as pharmaceutical in...

      10 Chapter 15Table 15.1 Standard parameters used for the simulation of SLP values for LR...Table 15.2 Comparison of SLP dependencies from theories (LRT and SWMBT) and...

      11 Chapter 16Table 16.1 Summary ofin vitro studies performed in recent years highlightin...Table 16.2In vivo toxicity results of SPIONs.Table 16.3 Some of the commercialized SPIONs which are used for different d...Table 16.4 Cytotoxicity of Fe₃O₄ nanoparticles in different cell lines.Table 16.5 Representative magnetic nanoparticles for magnetic nanoparticle‐...Table 16.6 The distribution of MNPs in organs and tissues, depending on the...

      12 Chapter 17Table 17.1 Size and shape control of the most reported synthesis methods of...Table 17.2 Some published values are reported in size, composition, and sha...

      13 Chapter 18Table 18.1 Summary of clinical trials on MHT using magnetic nanoparticles.Table 18.2 Nanoparticle constructs utilized for magnetic hyperthermia thera...Table 18.3 Summary of recent studies on magnetic fluid hyperthermia therapy...

      List of Illustrations

      1 Chapter 1Figure 1.1 (a) Schematic field dependencies of magnetization of (I) diamagne...Figure 1.2 Fe₃O₄ bulk unit cell (inverse spinel structure).Figure 1.3 (a) Representation of the magnetization vectors (

) and elementar...Figure 1.4 Magnetic structures of nanoparticles: multidomain nanoparticles w...Figure 1.5 Multidomain magnetic nanoparticles with (a) uniform magnetization...Figure 1.6 (a) Relative saturation magnetization of iron, cobalt, and nickel...Figure 1.7 (a) Specific saturation magnetization as a function of the mean d...Figure 1.8 (a) The crystallographic systems for Ni‐single crystal.(b) Ro...Figure 1.9 The crystallographic systems for Co‐single crystal.Figure 1.10 The crystal approximated by an ellipsoid (general case).Figure 1.11 The orientation of spontaneous magnetization

relative to norma...Figure 1.12 (a) Schematic view of the general spin canting geometry (the cor...Figure 1.13 (a) Schematic drawing of a core‐shell structure and (b) transmis...Figure 1.14 (a) Typical hysteresis loop for ferromagnetic materials.(b) ...Figure 1.15 (a) M versus H for (Zn_0.15Ni_0.85Fe₂O₄)_0.15/(SiO₂)_0.85 sample....Figure 1.16 (a) M versus H in low fields and (b) M versus 1/H in high fields...Figure 1.17 Nanoparticle energy as a function of ψ and φ angles fo...Figure 1.18 Illustration of the two components of the magnetic relaxation of...Figure 1.19 Schematic diagram of a single‐core magnetic nanoparticle. Note t...Figure 1.20 SLP for γ‐Fe₂O₃ nanoparticles.Figure 1.21 Different applications of magnetic NPs.Figure 1.22 A representation of the application of core and shell of magneti...

      2 Chapter 2Figure 2.1 Example of a NMRD profile for a colloidal suspension of SPIONs sh...Figure 2.2 (a) CT lymphography demonstrated a sentinel node (arrow). (b) The...Figure 2.3 (a) CT lymphography demonstrated a sentinel node (arrow). (b) The...Figure 2.4 MPI‐CT imaging of intravenously injected hMSCs, Resovist, and sal...

      3 Chapter 3Figure 3.1 Interactions between magnetic nanoparticles. (a) Schematic illust...Figure 3.2 Electrostatic stabilization of the nanoparticles by (a) Derjaguin...Figure Scheme 3.1 Schematic illustration of magnetic nanoparticles clusterin...Figure 3.3 Schematic illustration of the nanoclusters prepared by encapsulat...Figure 3.4 Schematic illustration of magnetic nanoclusters armed with PD‐1 a...

      4 Chapter 4Figure 4.1 Stimulus–responsive membrane triggering in vitro of the proposed ...Figure 4.2 Schematic representation of magnet‐scaffold configurations: (a) e...Figure 4.3 Effect of time‐dependent magnetic field on PCL and PCL/Fe₃O₄ subs...

      5 Chapter 5Figure 5.1 Number of published papers in the last decade, according to the W...Figure 5.2 Flowchart representing the main stages of production, scaffolding...

      6 Chapter 6Figure 6.1 Effect of external magnetic field on hydrogen nuclei associated w...Figure 6.2 Vector diagram of the precessing hydrogen nucleus. At any given i...Figure 6.3 Components of a typical clinical MRI machine. The MRI machine con...Figure 6.4 Effect of RF pulse on longitudinal and transverse magnetization. ...Figure 6.5 Longitudinal and transverse relaxation.Figure 6.6 Basic concepts of electrostatic layer‐by‐layer self‐assembly. In ...

      7 Chapter 7Figure 7.1 Schematic view for the targeting mechanisms.Figure 7.2 Schematic view for MTD delivery.Figure 7.3 MRI imaging diagnostics mechanism.

      8 Chapter